On April 11, 2024, John Chevedden announced that he has filed an exempt solicitation statement with Securities and Exchange Commission, requesting the shareholders of Quest Diagnostics Incorporated to vote for a proposal regarding issue near and long-term science-based greenhouse gas reduction targets aligned with the Paris Agreement?s ambition of limiting global temperature rise to 1.5 °C and summarize plans to achieve them, at the annual meeting of shareholders scheduled to be held on May 16, 2024.